Radiation Exposure Claims for Veterans
Veterans who participated in nuclear weapons testing, occupied Hiroshima or Nagasaki after World War II, or served at specific nuclear-related sites may be eligible for disability compensation through the Department of Veterans Affairs' radiation exposure framework. This page covers how VA defines radiation-related service connection, the mechanisms for establishing a claim, the exposure scenarios that qualify, and the boundaries that determine whether a condition is presumptive or must be proven through direct evidence. Understanding these distinctions is essential because the evidentiary burden differs substantially depending on the pathway a claim follows.
Definition and Scope
Radiation exposure claims fall under a specialized category of VA disability compensation designed to address veterans whose military service placed them in proximity to ionizing radiation — a category of energy that includes gamma rays, X-rays, alpha particles, and beta particles capable of damaging cellular DNA. VA's regulatory framework for these claims is codified at 38 C.F.R. § 3.309(d) and governed by the Radiation-Exposed Veterans Compensation Act, which has been amended multiple times since its original enactment.
The scope encompasses two distinct veteran populations: those exposed to radiation from participation in atmospheric nuclear tests (referred to as "atomic veterans") and those who occupied Hiroshima or Nagasaki, Japan, between August 6, 1945, and July 1, 1946. A third, broader category covers veterans exposed to ionizing radiation in other military contexts — such as service at gaseous diffusion plants, X-ray technician duties, or reactor operation — but this group faces a different evidentiary standard than the presumptive pathway.
Radiation exposure claims intersect with the broader landscape of VA disability compensation and connect to presumptive eligibility structures that also govern Agent Orange exposure benefits, burn pit and PACT Act claims, and Gulf War illness. The Veterans Authority home page offers orientation across all major benefit categories for veterans navigating multiple claim types simultaneously.
How It Works
VA processes radiation exposure claims through two parallel tracks, and the track applied determines how much medical and scientific evidence a veteran must produce.
Track 1 — Presumptive Service Connection
Under 38 C.F.R. § 3.309(d), veterans who meet the qualifying exposure criteria are presumed to have a service-connected disability if they develop one of 21 listed radiogenic diseases. For these veterans, VA does not require the claimant to establish a direct medical link between their specific radiation dose and their diagnosis. The listed conditions include:
Track 2 — Radiation Risk Activity (Non-Presumptive)
Veterans who were exposed to ionizing radiation through military duties outside the presumptive exposure categories — such as operating nuclear reactors, working at weapons production facilities, or receiving occupational X-ray exposure — must establish service connection through a dose reconstruction process. VA requests a radiation dose estimate from the Defense Threat Reduction Agency (DTRA), which applies methodologies established by the Department of Defense. VA then refers the file to its Under Secretary for Benefits, who applies a risk-based analysis under 38 C.F.R. § 3.311 to determine whether the veteran's cancer is at least as likely as not caused by radiation exposure.
The dose reconstruction step can take months and typically requires the veteran's military occupational specialty records, unit history, and any available health physics data from the relevant installation or command.
Common Scenarios
Atmospheric Nuclear Test Participation ("Atomic Veterans")
The United States conducted 235 atmospheric nuclear tests between 1945 and 1962 (U.S. Department of Energy, Nevada National Security Site). Veterans who participated in these tests — including those who entered blast areas for military exercises, operated equipment near detonation zones, or served as observers — qualify for the presumptive pathway if they develop a listed condition. The National Personnel Records Center (NPRC) in St. Louis holds unit assignment records used to verify participation.
Hiroshima and Nagasaki Occupation
Veterans who entered either city as part of the post-World War II occupation forces between August 6, 1945, and July 1, 1946, qualify for presumptive eligibility. This includes members of the Army of Occupation who were stationed in those cities regardless of whether their primary duties were combat-related.
Gaseous Diffusion Plant Workers
Veterans who worked at the K-25, Y-12, or Oak Ridge facilities in Tennessee, or at the Paducah Gaseous Diffusion Plant in Kentucky, during periods of active weapons-grade uranium enrichment are covered under the non-presumptive track and require DTRA dose reconstruction.
Medical and Occupational X-Ray Exposure
Veterans who served as medical X-ray technicians or radiological specialists may have accumulated occupational dose over extended service periods. These cases proceed under Track 2, and the cumulative dose estimate becomes the central evidentiary document.
Decision Boundaries
The distinction between presumptive and non-presumptive pathways represents the most consequential decision boundary in radiation exposure claims. A veteran who qualifies for Track 1 needs only to establish: (1) military service that included a qualifying radiation risk activity as defined in 38 C.F.R. § 3.309(d)(3), and (2) a current diagnosis of one of the 21 listed conditions. A Track 2 claimant must additionally survive a probabilistic risk analysis that considers dose magnitude, latency period, and the specific cancer's known radiosensitivity.
Chronic lymphocytic leukemia (CLL) is the most commonly litigated boundary condition. CLL is explicitly excluded from the presumptive list under 38 C.F.R. § 3.309(d) because scientific consensus at the time of the regulation held that CLL was not caused by radiation. However, VA has periodically reviewed this exclusion, and veterans with CLL may still pursue service connection under Track 2 if dose reconstruction supports the claim.
A second boundary involves the latency period. VA's risk analysis under § 3.311 considers whether sufficient time elapsed between exposure and diagnosis for a radiation-induced malignancy to develop. For leukemia, the minimum latency is typically 2 years; for solid tumors, the accepted latency is generally 5 years or longer. Claims where the diagnosis occurred within the minimum latency window face heightened scrutiny.
Veterans denied at the rating stage have the right to challenge the decision through the VA appeals process. The disability rating system applies to approved radiation claims in the same manner as all other service-connected conditions. Veterans seeking to understand the full scope of their eligibility across toxic exposure categories, including the 2022 PACT Act expansions, can consult the presumptive conditions list for a consolidated reference.